| Literature DB >> 19656358 |
Anne Margriet Pot1, France Portrait, Geraldine Visser, Martine Puts, Marjolein I Broese van Groenou, Dorly J H Deeg.
Abstract
BACKGROUND: It is well-known that the use of care services is most intensive in the last phase of life. However, so far only a few determinants of end-of-life care utilization are known. The aims of this study were to describe the utilization of acute and long-term care among older adults in their last year of life as compared to those not in their last year of life, and to examine which of a broad range of determinants can account for observed differences in care utilization.Entities:
Mesh:
Year: 2009 PMID: 19656358 PMCID: PMC2739193 DOI: 10.1186/1472-6963-9-139
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Composition of study sample
| Alive 3 years after cycle | Deceased 1 year After cycle | Total | |
| Cycle I | 2,738 | 117 | 2,855 |
| Cycle II | 2,028 | 80 | 2,108 |
| Cycle III | 1,638 | 65 | 1,703 |
| Total | 6,403 | 262 | 6,665 |
Characteristics of survivors and end-of-life group at each cycle: use of care, predisposing and enabling factors
| Cycle I Survivors (n = 2,737) | Deceased (n = 117) | Cycle II Survivors (n = 2,028) | Deceased (n = 80) | Cycle III Survivors (n = 1,638) | Deceased (n = 65) | |
| Acute care: Contact with medical specialists | 44.9 | 61.6* | 47.0 | 57.3* | 48.9 | 50.8* |
| Acute care: Hospital care | 9.5 | 24.2** | 9.3 | 19.5** | 8.2 | 16.4** |
| Long-term care: Informal personal care | 1.9 | 11.1*** | 1.3 | 7.5*** | 1.9 | 10.8*** |
| Long-term care: Professional home care | 1.9 | 20.5*** | 2.6 | 27.5*** | 3.2 | 24.6*** |
| Long-term care: Institutional care | 2.4 | 17.1*** | 2.7 | 22.5*** | 3.4 | 18.6*** |
| Age (mean) | 69.9 | 77.0*** | 71.7 | 79.0*** | 73.2 | 83.2*** |
| Female (%) | 53.5 | 36.8** | 55.3 | 40.0** | 56.8 | 39.0** |
| Education (%) | ||||||
| Low | 62.5 | 69.9 | 60.1 | 71.3 | 59.0 | 57.6 |
| Middle | 25.7 | 18.6 | 27.7 | 13.8 | 28.6 | 23.7 |
| High | 11.7 | 11.5 | 12.2 | 15.0 | 12.4 | 18.6 |
| Income in Euros (mean) | 1,135 | 1,041 | 1,180 | 1,091 | 1,193 | 1,221 |
| Urbanicity (%) | ||||||
| Low | 24.5 | 17.1 | 25.0 | 25.0 | 25.9 | 15.3 |
| Middle | 24.3 | 26.5 | 24.2 | 20.0 | 24.4 | 25.4 |
| High | 51.2 | 56.4 | 50.8 | 55.0 | 49.8 | 59.3 |
| Partner (%) | 67.7 | 53.0** | 63.9 | 51.3** | 62.1 | 47.5** |
| Children nearby (%) | 62.0 | 57.0 | 61.0 | 46.0 | 61.2 | 63.3 |
Significance tests at each cycle: * significant at p < 0.05, ** significant at p < 0.01, *** significant at p < 0.001
Figure 1Percentage users by age for each end-of-life status, all three cycles taken together. a. Medical specialist, b. Hospital care, c. Informal care, d. Professional home care, e. Institutional care
Characteristics of survivors and end-of-life group: need factors
| Cycle I Survivors (n = 2,737) | Deceased (n = 117) | Cycle II Survivors (n = 2,028) | Deceased (n = 80) | Cycle II Survivors (n = 1,638) | Deceased (n = 65) | |
| Functional limitations (%) | ||||||
| Score ≥ 2 | 26.1 | 62.2*** | 32.6 | 68.8*** | 35.9 | 78.6*** |
| Physical performance (%) | ||||||
| Score 3–5 | 31.3 | 8.3 | 33.0 | 15.4 | 27.2 | 8.5 |
| Score 6–7 | 26.5 | 18.8 | 24.2 | 13.8 | 22.9 | 10.6 |
| Score 8–10 | 26.7 | 34.4 | 27.4 | 27.7 | 30.1 | 27.7 |
| Score 11–15 | 15.4 | 38.5*** | 15.3 | 43.1*** | 19.8 | 53.2*** |
| Disability (%) | ||||||
| No | 70.5 | 43.0 | 64.5 | 30.4 | 62.3 | 36.2 |
| Mild | 18.7 | 25.4 | 23.4 | 32.9 | 24.6 | 34.5 |
| Severe | 10.8 | 31.6*** | 12.1 | 36.7*** | 13.1 | 29.3*** |
| Number Chronic diseases (mean) | 1.3 | 2.0*** | 1.6 | 2.3*** | 1.9 | 2.5*** |
| COPD | 10.6 | 25.7*** | 12.7 | 24.1*** | 14.3 | 25.4*** |
| Heart diseases | 18.2 | 31.6*** | 22.7 | 42.3*** | 25.9 | 46.0*** |
| Artery disease | 8.6 | 12.4* | 11.3 | 36.7** | 11.4 | 23.8** |
| Stroke | 4.8 | 13.2*** | 6.3 | 16.5*** | 7.1 | 22.2*** |
| Diabetes | 6.1 | 21.1** | 7.4 | 16.5** | 8.5 | 11.5 |
| Arthritis | 35.0 | 32.5 | 46.4 | 39.2 | 51.5 | 57.1 |
| Cancer | 8.4 | 16.7** | 10.8 | 21.5** | 13.0 | 15.9 |
| Difficulty Seeing (%) | 21.1 | 29.6* | 21.9 | 33.8* | 22.6 | 34.4* |
| Difficulty Hearing (%) | 31.8 | 38.8 | 34.4 | 40.0 | 31.6 | 42.2 |
| Self-rated Health Fair to poor (%) | 36.0 | 52.2*** | 34.7 | 68.4*** | 34.0 | 53.2*** |
| Cognitive impairment: MMSE Score ≥ 23 (%) | 5.9 | 24.8*** | 6.9 | 26.6*** | 5.8 | 30.5*** |
| Depressive symptoms: CES-D Score ≥ 16 (%) | 11.4 | 19.8** | 11.9 | 27.3** | 13.9 | 25.0** |
Significance tests at each cycle: * significant at p < 0.05, ** significant at p < 0.01, *** significant at p < 0.001
The association of end-of-life status with acute and long-term care utilisation: adjusted for all predisposing, enabling and need variables (logistic regression coefficients from Generalized Estimating Equations)
| Model 11 | Model 22 | Model 33 | |
| Acute care: Contact with medical specialists | 0.22+ | 0.27+ | -0.11 |
| Acute care: Hospital care | 0.77*** | 0.61* | 0.14 |
| Long-term care: Informal personal care | 1.43*** | 1.59*** | 0.66 |
| Long-term care: Professional home care | 1.78*** | 1.58*** | 0.78+ |
| Long-term care: Institutional care | 1.11*** | 1.33*** | 0.65* |
1 adjusted for age and gender (predisposing variables)
2 adjusted for age and gender (predisposing variables), education, income, urbanicity, partner status, and number of children within 15 minutes travel distance (enabling variables)
3 adjusted for age and gender (predisposing variables), education, income, urbanicity, partner status, and number of children within 15 minutes travel distance (enabling variables), and functional limitations, disability, physical performance, number of chronic diseases, seeing, hearing, self-reported health, cognitive impairment, and depressive symptoms (need variables)
+ significant at p <0.10, * significant at p < 0.05, ** significant at p < 0.01, *** significant at p < 0.001
Determinants of acute and long-term care utilisation: end-of-life status and predisposing, enabling and need variables (logistic regression coefficients from Generalised Estimating Equations)
| Acute care | Long-term care | ||||
| Determinants | Medical specialist | Hospital care | Informal personal care | Professional home care | Institutional care |
| End of life | -0.109 | 0.141 | 0.656 | 0.781+ | 0.649* |
| Age per year | 0.017*** | 0.007 | 0.001 | 0.079* | 0.111*** |
| Female sex | -0.183* | -0.234* | -0.296 | -0.517 | -0.765* |
| Education (1–3) | 0.147* | -0.064+ | 0.412+ | 0.567 | 0.397 |
| Income (per €100) | 0.002 | 0.02 | 0.006 | -0.036 | -0.167** |
| Partner | 0.218** | 0.210+ | 2.187*** | -0.498 | -0.48 |
| Children nearby | -0.007 | 0.012 | 0.170** | 0.185* | -0.04 |
| Urbanicity (1–3) | 0.198*** | 0.04 | 0.018 | -0.420* | 0.046 |
| Functional Limitations (0–9) | -0.02 | 0.008 | 0.259*** | 0.520*** | 0.287*** |
| Disability (1–3) | 0.350*** | 0.368*** | 0.397+ | 0.501* | -0.047 |
| Performance (3–15) | 0.02 | 0.060** | 0.474*** | 0.102 | 0.249** |
| Number Chronic Diseases | 0.425*** | 0.151*** | 0.101 | 0.317* | -0.088 |
| Vision | 0.126* | 0.042 | -0.119 | 0.054 | 0.101 |
| Hearing | 0.031 | -0.012 | -0.157 | 0.08 | -0.003 |
| Self-Rated Health | 0.338*** | 0.204** | 0.092 | 0.124 | -0.109 |
| Cognitive impairment (0–30) | 0.034* | -0.001 | 0.003 | 0.012 | -0.065+ |
| Depressive symptoms (0–60) | -0.004 | 0.007 | 0.015 | 0.029 | 0.009 |
| Model fit (Wald chi2 (df = 17)) | 669.85 | 320.05 | 236.91 | 181.05 | 210.14 |
+ significant at p < 0.10, * significant at p < 0.05, ** significant at p < 0.01, *** significant at p < 0.001